Pricing Log in Create free account

BeyondSpring Inc. (BYSI) vs Metagenomi Therapeutics, Inc. (MGX)

BeyondSpring Inc. and Metagenomi Therapeutics, Inc. are both Biotechnology companies. BeyondSpring Inc. and Metagenomi Therapeutics, Inc. are of similar size ($27.6M and $26.0M). BeyondSpring Inc. has the higher net margin (0.00% vs −689.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, BeyondSpring Inc. leads on 9 and Metagenomi Therapeutics, Inc. on 3.

Valuation

Metric BYSI MGX Biotechnology median
P/E n/m n/m 10.60
P/S 18.57 1.94 9.40
P/B n/m 0.23 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.66 0.66
EV/Sales 15.37 (4.72) 9.02
Earnings yield (28.28%) (355.71%) (32.88%)
Free cash flow yield (66.96%) (325.47%) (23.13%)

Profitability

Metric BYSI MGX Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% (741.58%) 0.00%
Net margin 0.00% (689.20%) 0.00%
Free cash flow margin 0.00% (632.67%) 0.00%
Return on equity 24.96% (60.61%) (51.96%)
Return on assets (29.29%) (41.91%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BYSI MGX Biotechnology median
Revenue growth (TTM) — (59.84%) 6.76%
EPS growth (last fiscal year) 92.86% 0.00% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BYSI MGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.70 4.50 4.97
Net debt to EBITDA 1.42 1.71 1.01

Dividend

Metric BYSI MGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BYSI MGX Biotechnology median
Market cap 26.00m 27.60m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack